Forget the best easy-access savings rate. I’d pick up a 5.1% yield with GSK shares

You could earn 1.5% from a savings account, or you could pick up 5.1% from GlaxoSmithKline plc (LON: GSK) shares, explains Edward Sheldon.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s a tough time for UK savers right now. With the best rates on easy-access savings accounts hovering around the 1.5% mark, £10,000 in cash savings will only net you around £150 in interest for the year. Uninspiring, isn’t it?

However, look to the stock market and you’ll see that there are plenty of FTSE 100 stocks that are currently offering dividend yields way higher than 1.5% at present. In fact, right now, it’s possible to pick up yields of 5% or higher from a number of well known, large-cap stocks. Here’s a look at one FTSE 100 dividend stock I’d buy for its big yield.

GlaxoSmithKline

GlaxoSmithKline (LSE: GSK) is a global healthcare company that operates through three segments: pharmaceuticals, vaccines, and consumer healthcare. The group develops and manufactures a broad range of prescription medicines and vaccines, and also develops and markets a range of wellness, oral health, nutrition, and skin health products through its consumer healthcare unit. With a market capitalisation of a huge £77bn, GSK is one of the largest stocks in the FTSE 100.

Big dividend yield

GSK is known for being a big dividend payer. For the last four years, it has paid shareholders 80p per share in dividends each year, which at the current share price of 1,560p translates to a yield of 5.1% – more than three times the best easy-access savings interest rate.

I’ll point out that GSK probably isn’t the ‘perfect’ dividend stock, as it hasn’t increased its dividend in a few years now which is a little frustrating for long-term shareholders. That said, a yield of 5.1% is not something to complain about in the current low-interest-rate environment, in my view. 

Long-term growth story

Aside from the high yield, other reasons I like the look of GSK shares right now are the stock’s reasonable valuation (P/E of 13.8), the defensive nature of the business (demand for drugs and healthcare products is unlikely to drop as a result of Brexit) and the long-term growth story associated with the world’s ageing population.

You see, the global population is ageing fast as people live for longer. Here in the UK, those aged 65 and older made up 17.8% of the population in 2015. Yet by 2045, this segment of the population is expected to make up nearly 25% of the population, according to the Office for National Statistics. What’s the one key thing people have a higher demand for as they age? Healthcare products. As such, GlaxoSmithKline, as a healthcare specialist, looks well placed to benefit from this dominant structural trend over the long term.

Of course, investing in shares is riskier than putting your cash in a bank. When you buy shares, your money will fluctuate in value and that means there’s a chance you may not get back what you invested. Yet risk is related to reward, and when you consider that there’s a 5.1% yield on offer and the chance to invest in a long-term growth story, I think the risk of buying GSK shares is definitely worth considering.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon owns shares in GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

How I’d invest my first £20k ISA to target £4,900 a year from dividend shares

Looking for dividend shares in a new Stocks and Shares ISA, and want diversification too? Here's how I'd go about…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »